Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix’s Proposed Merger with Akoya Biosciences
Quanterix Corporation (QTRX)
US:NASDAQ Investor Relations:
ir.quanterix.com/investor-relations
Company Research
Source: Business Wire
Believes Transaction Significantly Undervalues QuanterixHighlights that Quanterix’s Board is Essentially Rescuing Akoya at the Direct Expense of Quanterix ShareholdersTransaction Would Introduce Unnecessary Risk and Divert Cash and Management Focus Away from Quanterix’s Alzheimer’s Diagnostics Program, a Core Growth OpportunityCalls on Quanterix Board to Answer Pressing Questions around Valuation, Process and Governance Issues in Connection with TransactionUrges Shareholders to Vote Against Merger with Akoya to Protect the Future Value of Their Investment RINCON, Puerto Rico--(BUSINESS WIRE)--Kent Lake PR LLC (“Kent Lake”) a holder of 7.25% of the outstanding common stock of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), today issued a presentation to Quanterix shareholders in connection to Kent Lake’s opposition to the Company’s proposed transaction (the “Transaction”) with Akoya Biosciences (“Akoya”) (NASDAQ: AKYA).Kent Lake’s full presentation is available
Show less
Read more
Impact Snapshot
Event Time:
QTRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QTRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QTRX alerts
High impacting Quanterix Corporation news events
Weekly update
A roundup of the hottest topics
QTRX
News
- Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth [Yahoo! Finance]Yahoo! Finance
- Quanterix Announces Board and Leadership Changes to Support Next Stage of GrowthBusiness Wire
- Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring [Yahoo! Finance]Yahoo! Finance
- Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis MonitoringBusiness Wire
- Alzheimer Biomarker Based Diagnostic Research Report 2025-2035: Market to Transform with Rise of Blood-Based Tests, Emerging as a Less Invasive and Scalable Alternative to CSF and PET Methods [Yahoo! Finance]Yahoo! Finance
QTRX
Earnings
- 11/10/25 - Miss
QTRX
Sec Filings
- 12/18/25 - Form 4
- 12/18/25 - Form 4
- 12/8/25 - Form 4
- QTRX's page on the SEC website